July 25, 2014 10:56 AM ET

Healthcare Equipment and Supplies

Company Overview of Adaltis Inc.

Company Overview

Adaltis Inc. develops, manufactures, and markets in vitro diagnostic systems and reagent products to detect viral infections, diagnose immune system diseases, and measure human hormone responses. It offers diagnostic products, including automated diagnostic systems consisting of instruments, reagents, and software, which test a range of medical conditions. The company’s primary products include Eclectica, a closed random access instrument for immunoassay, clinical chemistry, specific protein, and electrolyte tests, as well as fertility/thyroid, diabetes, and oncology tests; and Nexgen Four/Personal Lab instruments, which are used in the testing of hepatitis, HIV, syphilis, TORCH, thyroid, an...

10 900 Hamon Street

Montreal, QC H3M 3A2


Founded in 1987

261 Employees





Key Executives for Adaltis Inc.

Adaltis Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Iaculor Injection Inc. Americas
NeuroArm Surgical Limited Americas
Groupe Bertec Inc. Americas
SciCan Ltd. Americas
Biogentis Inc. Americas

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Adaltis Inc., please visit www.adaltis.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.